AtriCure to Participate at Upcoming Investor Conferences
July 20 2022 - 8:00AM
Business Wire
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical
treatments for atrial fibrillation (Afib), left atrial appendage
(LAA) management, and post-operative pain management, today
announced that the company will be participating in two upcoming
investor conferences.
AtriCure will be participating in the Canaccord Genuity 42nd
Annual Growth Conference. AtriCure’s management is scheduled to
present on Thursday, August 11, 2022, at 10:00 a.m. Eastern Time.
Interested parties may access a live audio webcast of the
presentation by visiting the “Investors” section of the company’s
website at https://ir.atricure.com.
AtriCure’s management will also be participating in meetings at
the 7th Annual Needham Virtual Med Tech & Diagnostics
Conference, scheduled to be held virtually, on Monday, August 15,
2022.
About AtriCure
AtriCure, Inc. provides innovative technologies for the
treatment of Afib and related conditions. Afib affects more than 33
million people worldwide. Electrophysiologists and cardiothoracic
surgeons around the globe use AtriCure technologies for the
treatment of Afib and reduction of Afib related complications.
AtriCure’s Isolator® Synergy™ Ablation System is the first medical
device to receive FDA approval for the treatment of persistent
Afib. AtriCure’s AtriClip® Left Atrial Appendage Exclusion System
products are the most widely sold LAA management devices worldwide.
AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure
that provides a lasting solution for long-standing persistent Afib
patients. AtriCure’s cryoICE cryoSPHERE® probe is cleared for
temporary ablation of peripheral nerves to block pain, providing
pain relief in cardiac and thoracic procedures. For more
information, visit AtriCure.com or follow us on Twitter
@AtriCure.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220720005059/en/
Angie Wirick AtriCure, Inc. Chief Financial Officer (513)
755-5334 awirick@atricure.com
Lynn Lewis Gilmartin Group Investor Relations
lynn@gilmartinir.com
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Mar 2024 to Apr 2024
AtriCure (NASDAQ:ATRC)
Historical Stock Chart
From Apr 2023 to Apr 2024